Insider sale
TEMPEST THERAPEUTICS, INC.
$967.0K
788K shares
What this filing means
VERSANT VENTURE CAPITAL VI, L.P. plans to sell 788K shares of TEMPEST THERAPEUTICS, INC. valued at approximately $967.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2024ACC: 0000950170-24-095769
10% Owner
Since Jun 2021
788K
Shares to sell
$967.0K
Approx. market value
1.16M
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
private offering
cash
2/6/2019
388Kprivate offering
cash
2/6/2019
388Kprivate offering
cash
2/6/2019
388KTotal acquired1.16M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/6/2019 | private offering cash | 388K | — |
2/6/2019 | private offering cash | 388K | — |
2/6/2019 | private offering cash | 388K | — |
| Total | 1.16M | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
400K
Market value
$540.0K
8/8/2024
Planned — Approximate Date
NasdaqPlanned
Units to sell
388K
Market value
$427.0K
8/12/2024
Total
Units
788K
Value
$967.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/8/2024 | 400K | $540.0K | — | Completed |
| Planned — Approximate Date | ||||
8/12/2024 | 388K | $427.0K | Nasdaq | Planned |
| Total | 788K | $967.0K | ||